Adaptive Biotechnologies Corp — Director's Dealing 2019

Oct 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2019-10-23

Reporting Person: ROBINS CHAD M (Director, CEO and Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-23	Common Stock	M	20000	$0.33	Acquired	1878180	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-23	Stock Option (Right to Buy)	$0.33	M	20000	Disposed	2021-12-20	Common Stock (20000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2237500	Indirect
Common Stock	500000	Indirect
Common Stock	350000	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

F2: The option is fully vested and exercisable.